☰

Felicity C. Stark, Ph.D. - Publications

Affiliations: 
2011 Biochimie, microbiologie et immunologie / Biochemistry, Microbiology and Immunology University of Ottawa, Ottawa, ON, Canada 
Area:
Immunology, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Akache B, Read AJ, Dudani R, Harrison BA, Williams D, Deschatelets L, Jia Y, Chandan V, Stark FC, Agbayani G, Makinen SR, Hemraz UD, Lam E, Régnier S, Zou W, et al. Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious. Vaccines. 11. PMID 37376432 DOI: 10.3390/vaccines11061043  0.396
2022 Stark FC, Akache B, Deschatelets L, Tran A, Stuible M, Durocher Y, McCluskie MJ, Agbayani G, Dudani R, Harrison BA, Renner TM, Makinen SR, Bavananthasivam J, Duque D, Gagne M, et al. Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters. Scientific Reports. 12: 9772. PMID 35697917 DOI: 10.1038/s41598-022-13819-5  0.369
2022 Régnier S, Lam E, Vasquez V, Martinez-Farina CF, Stark FC, Agbayani G, Deschatelets L, Dudani R, Harrison BA, Akache B, McCluskie MJ, Hemraz UD. Effect of Chiral Purity on Adjuvanticity of Archaeol-Based Glycolipids. Journal of Medicinal Chemistry. PMID 35658102 DOI: 10.1021/acs.jmedchem.2c00072  0.38
2022 Akache B, Stark FC, Agbayani G, Renner TM, McCluskie MJ. Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines. Methods in Molecular Biology (Clifton, N.J.). 2412: 179-231. PMID 34918246 DOI: 10.1007/978-1-0716-1892-9_9  0.323
2021 Liu QY, Leclerc S, Pan Y, Liu Z, Stark F, Conlan JW. Novel Transcriptional and Translational Biomarkers of Tularemia Vaccine Efficacy in a Mouse Inhalation Model: Proof of Concept. Microorganisms. 10. PMID 35056485 DOI: 10.3390/microorganisms10010036  0.312
2021 Akache B, Agbayani G, Stark FC, Jia Y, Dudani R, Harrison BA, Deschatelets L, Chandan V, Lam E, Hemraz UD, Régnier S, Krishnan L, McCluskie MJ. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model. Pharmaceutics. 13. PMID 33673382 DOI: 10.3390/pharmaceutics13020257  0.556
2021 Jia Y, Akache B, Agbayani G, Chandan V, Dudani R, Harrison BA, Deschatelets L, Hemraz UD, Lam E, Régnier S, Stark FC, Krishnan L, McCluskie MJ. The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model. Pharmaceutics. 13. PMID 33540932 DOI: 10.3390/pharmaceutics13020205  0.351
2021 Stark FC, Dudani R, Agbayani G, McCluskie MJ. A Method to Evaluate In Vivo CD8 T Cell Cytotoxicity in a Murine Model. Methods in Molecular Biology (Clifton, N.J.). 2183: 549-558. PMID 32959267 DOI: 10.1007/978-1-0716-0795-4_32  0.537
2021 Akache B, Stark FC, McCluskie MJ. Measurement of Antigen-Specific IgG Titers by Direct ELISA. Methods in Molecular Biology (Clifton, N.J.). 2183: 537-547. PMID 32959266 DOI: 10.1007/978-1-0716-0795-4_31  0.306
2021 Agbayani G, Stark FC, Akache B, McCluskie MJ. Methods to Evaluate Immune Cell Recruitment and Cellular Uptake and Distribution of Antigen Following Intramuscular Administration of Vaccine to Mice. Methods in Molecular Biology (Clifton, N.J.). 2183: 513-524. PMID 32959264 DOI: 10.1007/978-1-0716-0795-4_29  0.429
2020 Agbayani G, Jia Y, Akache B, Chandan V, Iqbal U, Stark FC, Deschatelets L, Lam E, Hemraz UD, Régnier S, Krishnan L, McCluskie MJ. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations. Human Vaccines & Immunotherapeutics. 1-13. PMID 32755430 DOI: 10.1080/21645515.2020.1788300  0.521
2019 Stark FC, Agbayani G, Sandhu JK, Akache B, McPherson C, Deschatelets L, Dudani R, Hewitt M, Jia Y, Krishnan L, McCluskie MJ. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma. Biomedicines. 7. PMID 31771150 DOI: 10.3390/biomedicines7040091  0.598
2019 Stark FC, Akache B, Ponce A, Dudani R, Deschatelets L, Jia Y, Sauvageau J, Williams D, Jamshidi MP, Agbayani G, Wachholz K, Harrison BA, Li X, Krishnan L, Chen W, et al. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization. Vaccine. PMID 31383490 DOI: 10.1016/j.vaccine.2019.07.010  0.346
2019 Jia Y, Akache B, Deschatelets L, Qian H, Dudani R, Harrison BA, Stark FC, Chandan V, Jamshidi MP, Krishnan L, McCluskie MJ. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations. International Journal of Pharmaceutics. PMID 30836154 DOI: 10.1016/j.ijpharm.2019.02.041  0.4
2018 Akache B, Stark FC, Jia Y, Deschatelets L, Dudani R, Harrison BA, Agbayani G, Williams D, Jamshidi MP, Krishnan L, McCluskie MJ. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice. Plos One. 13: e0208067. PMID 30513093 DOI: 10.1371/Journal.Pone.0208067  0.427
2018 Akache B, Stark FC, Iqbal U, Chen W, Jia Y, Krishnan L, McCluskie MJ. Safety and Biodistribution of Sulfated Archaeal Glycolipid Archaeosomes as Vaccine Adjuvants. Human Vaccines & Immunotherapeutics. 0. PMID 29336668 DOI: 10.1080/21645515.2017.1423154  0.42
2017 Stark FC, Weeratna RD, Deschatelets L, Gurnani K, Dudani R, McCluskie MJ, Krishnan L. An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma. Vaccines. 5. PMID 29072624 DOI: 10.3390/vaccines5040038  0.489
2016 Stark FC, McCluskie MJ, Krishnan L. Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8⁺ T Cells that Protect Against Subcutaneous B16-OVA Melanoma. Vaccines. 4. PMID 27869670 DOI: 10.3390/vaccines4040044  0.554
2012 Stark FC, Gurnani K, Sad S, Krishnan L. Lack of functional selectin ligand interactions compromises long term tumor protection by CD8+ T cells. Plos One. 7: e32211. PMID 22359671 DOI: 10.1371/Journal.Pone.0032211  0.507
2010 Krishnan L, Deschatelets L, Stark FC, Gurnani K, Sprott GD. Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses. Clinical & Developmental Immunology. 2010: 578432. PMID 21318177 DOI: 10.1155/2010/578432  0.543
2009 Stark FC, Sad S, Krishnan L. Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection. Cancer Research. 69: 4327-34. PMID 19435919 DOI: 10.1158/0008-5472.Can-08-3160  0.536
Show low-probability matches.